Oxytocin receptor signalling

Progress in Brain Research

Volumn 170, Issue , 2008, Pages 167-176

  Devost, Dominic ^a   Wrzal, Paulina ^a   Zingg, Hans H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

contraction in vitro assay; elongation factor 2; ERK5; MAP kinases; oxytocin; oxytocin receptor; trophic action

Indexed keywords

ENZYME ANTIBODY; INITIATION FACTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MYOSIN LIGHT CHAIN; OXYTOCIN RECEPTOR; PHORBOL ESTER; PHOSPHOTHREONINE; PROTEIN KINASE C; SYNAPTOPHYSIN; THREONINE; TYROSINE;

AMINO TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MATURATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; MOLECULAR WEIGHT; MUSCLE CELL; MUSCLE FUNCTION; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ELONGATION FACTOR 2 KINASE; FEMALE; MILK; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 7; MUSCLE CONTRACTION; MYOMETRIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROLACTIN; RECEPTORS, OXYTOCIN; SEXUAL BEHAVIOR; SEXUAL BEHAVIOR, ANIMAL; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; UTERINE CONTRACTION;

EID: 47549117545     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00415-9     Document Type: Review

References (27)

1. Ahn S., Shenoy S.K., Wei H., and Lefkowitz R.J. Differential kinetic and spatial patterns of beta-arrestin2 and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 279 (2004) 35518-35525
2. Browne G.J., and Proud C.G. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269 (2002) 5360-5368
3. Cassoni P., Sapino A., Marrocco T., Chini B., and Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J. Neuroendocrinol. 16 (2004) 362-364
4. Devost D., Carrier M.E., and Zingg H.H. Oxytocin-induced activation of eukaryotic elongation factor eEF2 in myometrial cells is mediated by protein kinase C. Endocrinology 149 (2008) 131-138
5. Devost D., Girotti M., Carrier M.E., Russo C., and Zingg H.H. Oxytocin induces dephosphorylation of eukaryotic elongation factor 2 in human myometrial cells. Endocrinology 146 (2005) 2265-2270
6. Devost D., and Zingg H.H. Novel in vitro system for functional assessment of oxytocin action. Am. J. Physiol. 292 (2007) E1-E6
7. French/Australian Atosiban Investigators Group. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur. J. Obstet. Gynaecol. Reprod. Biol. 98 (2001) 177-185
8. Fuchs A.R., Fuchs F., Husslein P., and Soloff M.S. Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. 150 (1984) 734-741
9. Galandrin S., and Bouvier M. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 70 (2006) 1575-1584
10. Gimpl G., and Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 81 (2001) 629-683
11. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351 (1996) 127-134
12. Larcher A., Neculcea J., Breton C., Arslan A., Rozen F., Russo C., and Zingg H.H. Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. Endocrinology 136 (1995) 5350-5356
13. Li Y., Je H.D., Malek S., and Morgan K.G. ERK1/2-mediated phosphorylation of myometrial caldesmon during pregnancy and labor. Am. J. Physiol. 284 (2003) R192-R199
14. Lim M.M., and Young L.J. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm. Behav. 50 (2006) 506-517
15. Mody N., Leitch J., Armstrong C., Dixon J., and Cohen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 502 (2001) 21-24
16. Ohmichi M., Koike K., Nohara A., Kanda Y., Sakamoto Y., Zhang Z.X., Hirota K., and Miyake A. Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 136 (1995) 2082-2087
17. Phillippe M. Protein kinase C, an inhibitor of oxytocin-stimulated phasic myometrial contractions. Biol. Reprod. 50 (1994) 855-859
18. Reinheimer T.M. Barusiban suppresses oxytocin-induced preterm labour in non-human primates. BMC Pregnancy Childbirth 7 Suppl 1 (2007) S15
19. Reversi A., Rimoldi V., Marrocco T., Cassoni P., Bussolati G., Parenti M., and Chini B. The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism. J. Biol. Chem. 280 (2005) 16311-16318
20. Rimoldi V., Reversi A., Taverna E., Rosa P., Francolini M., Cassoni P., Parenti M., and Chini B. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. Oncogene 22 (2003) 6054-6060
21. Saito K., Haruki A., Ishikawa H., Takahashi T., Nagase H., Koyama M., Endo M., and Hirahara F. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage. J. Obstet. Gynaecol. Res. 33 (2007) 254-258
22. Soloff M.S., Alexandrova M., and Fernstrom M.J. Oxytocin receptors: triggers for parturition and lactation?. Science 204 (1979) 1313-1315
23. Strakova Z., Copland J.A., Lolait S.J., and Soloff M.S. ERK2 mediates oxytocin-stimulated PGE2 synthesis. Am. J. Physiol. 274 (1998) E634-E641
24. The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Br. J. Obst. Gynaecol. 108 (2001) 133-142
25. Zhong M., Yang M., and Sanborn B.M. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation. Endocrinology 144 (2003) 2947-2956
26. Zingg H.H. Oxytocin. In: De Groot L.J., and Jameson J.L. (Eds). Endocrinology. 4th ed. (2000), W B Saunders Comp., Philadelphia 201-208
27. Zingg H.H., and Laporte S.A. The oxytocin receptor. Trends Endocrinol. Metab. 14 (2003) 222-227